Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Biotechs: Still Well Placed For More Gains

17h seekingalpha
Big Pharma has to build out pipelines in new areas, and M&A is a compelling alternative. (719-3)

ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk

2018-02-16 seekingalpha
I remind readers of our biggest loser to date and why risk management has been key to ROTY`s success. (146-0)

MYOK / MyoKardia, Inc. / Partner Fund Management, L.P. - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    SCHEDULE 13G (Rule 13d-102)   Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1 )*     Myokardia, Inc.     (Name of Issuer)           Common stock, par value $0.0001 per share     (Title of Class of Securities)       62857M105     (CUSIP Number)       December 31, 2017     Date of Event Which Requires Filing of the Statement     Check the appropriate b

MYOK / MyoKardia, Inc. / Partner Fund Management, L.P. - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    SCHEDULE 13G (Rule 13d-102)   Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1 )*     Myokardia, Inc.     (Name of Issuer)           Common stock, par value $0.0001 per share     (Title of Class of Securities)       62857M105     (CUSIP Number)       December 31, 2017     Date of Event Which Requires Filing of the Statement     Check the appropriate b

ROTY Edition 1 Volume 79: Limited Downside Catalysts Vs. Binary Risk

2018-02-14 seekingalpha
We discuss the difference between binary catalysts and those with limited downside, utilizing two recent examples. (166-3)

BRIEF-Myokardia Begins Patient Dosing In Phase 1B Clinical Study Of Myk-491

2018-02-14 reuters
* MYOKARDIA BEGINS PATIENT DOSING IN PHASE 1B CLINICAL STUDY OF MYK-491 IN DILATED CARDIOMYOPATHY PATIENTS (1-0)

MYOK / MyoKardia, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-14 sec.gov
SCHEDULE 13G Amendment No. 5 MYOKARDIA INC COMMON STOCK Cusip #62857M105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #62857M105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 755,491 Item 6: 0 Item 7: 4,506,577 Item 8: 0 Item 9: 4,506,577 Item 11: 12.608% Item 12: HC Cusip #62857M105 Item 1: Reporting Person - Abigail P.

MYOK / MyoKardia, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-14 sec.gov
SCHEDULE 13G Amendment No. 5 MYOKARDIA INC COMMON STOCK Cusip #62857M105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #62857M105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 755,491 Item 6: 0 Item 7: 4,506,577 Item 8: 0 Item 9: 4,506,577 Item 11: 12.608% Item 12: HC Cusip #62857M105 Item 1: Reporting Person - Abigail P.

MYOK / MyoKardia, Inc. / Sanofi - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)*     MyoKardia, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62857M105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1

MYOK / MyoKardia, Inc. / Sanofi - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)*     MyoKardia, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62857M105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1

MYOK / MyoKardia, Inc. / Third Rock Ventures II, L.P. - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)*     MYOKARDIA, INC. (Name of Issuer)     COMMON STOCK, $0.0001 PAR VALUE PER SHARE (Title of Class of Securities) 62857M105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c

MYOK / MyoKardia, Inc. / Third Rock Ventures II, L.P. - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)*     MYOKARDIA, INC. (Name of Issuer)     COMMON STOCK, $0.0001 PAR VALUE PER SHARE (Title of Class of Securities) 62857M105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c

ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines

2018-02-13 seekingalpha
As always, readers are encouraged to do their own due diligence, manage risk appropriately, and avoid blindly following. (313-2)

MYOK / MyoKardia, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-09 sec.gov
SCHEDULE 13G Amendment No. 4 MYOKARDIA INC COMMON STOCK Cusip #62857M105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #62857M105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 184,107 Item 6: 0 Item 7: 2,578,756 Item 8: 0 Item 9: 2,578,756 Item 11: 7.215% Item 12: HC Cusip #62857M105 Item 1: Reporting Person - Abigail P.

MYOK / MyoKardia, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-09 sec.gov
SCHEDULE 13G Amendment No. 4 MYOKARDIA INC COMMON STOCK Cusip #62857M105 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #62857M105 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 184,107 Item 6: 0 Item 7: 2,578,756 Item 8: 0 Item 9: 2,578,756 Item 11: 7.215% Item 12: HC Cusip #62857M105 Item 1: Reporting Person - Abigail P.


CUSIP: 62857M105